Side effects in melanoma patients receiving adjuvant interferon alfa-2b therapy: a nurses perspective
Supportive Care in Cancer, 05/08/2012Rubin KM et al.
The considerable side effects of high–dose IFN alfa–2b (HDI) can be managed using established strategies. Oncology nurses play a significant role in the management of patients with melanoma receiving adjuvant HDI, and their prompt recognition of side effects, together with an understanding of effective pharmacological and nonpharmacological interventions, will improve patient comfort; this has the potential to positively influence treatment adherence and completion of the recommended treatment course.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.